ArticleOncotarget2016

Early onset of hypertension and serum electrolyte changes as potential predictive factors of activity in advanced HCC patients treated with sorafenib: results from a retrospective analysis of the HCC-AVR group.

Andrea Casadei Gardini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.